Merck Chief Executive Robert Davis's total compensation fell 10% in 2025, mostly due to lower stock and option awards. The executive was awarded a total compensation of $20.8 million in 2025, down ...
We recently published 12 Stocks on Jim Cramer’s Radar. Merck & Co., Inc. (NYSE:MRK) is one of the stocks on Jim Cramer's radar. Merck & Co., Inc. (NYSE:MRK) is one of the largest pharmaceutical ...
Merck is partnering with Infinimmune in a deal worth up to $838 million to leverage AI-driven antibody discovery. Do you know ...
Merck & Co., Inc. (NYSE:MRK) is one of the best affordable stocks to buy with good earnings growth. Merck & Co., Inc.
Rahway-headquartered Merck announced Feb. 23 it is restructuring its Human Health division. The move aims to strengthen commercial execution and support a growing, diversified pipeline. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results